fluorexon has been researched along with Benign Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Huang, Y; Jiang, X; Liu, X; Ma, P; Mu, X; Song, D; Wang, W; Zhang, S; Zhang, Y | 1 |
| Kim, HS; Lee, JS; Park, JH; Sharma, S; Shin, JK; Yoon, S | 1 |
| González, S; López-Soto, A; Lorenzo-Herrero, S; Sordo-Bahamonde, C | 1 |
| Ambre, AH; Gange, KN; Haldar, MK; Katti, KS; Layek, B; Mallik, S; Meghnani, V; Nahire, R; Paul, S; Sarkar, K; Singh, J | 1 |
| Chowdhury, P; Lin, FT; Lin, GE; Lin, WC; Liu, K; Song, Y | 1 |
| Lee, LJ; Lee, RJ; Li, H; Mao, W; Piao, L; Wu, J; Xiang, G; Yu, B; Zhai, G | 1 |
| Clerkin, K; Liang, JF; Shah, K; Tu, Z; Volk, M | 1 |
| Chang, J; Gong, X; Liang, X; Niu, R; Song, T; Wang, H; Zhao, P | 1 |
| André, T; Bagû, AC; Brock, R; Gückel, B; Hoff, A; Roth, G; Wiesmüller, KH | 1 |
| Beck, BH; Bodenstine, TM; Cook, LM; Diers, AR; Ismail, A; Landar, A; Vaidya, KS; Welch, DR | 1 |
| Antony, AC; Guo, L; Jayaram, HN; Roeske, RW; Zhang, Y | 1 |
| Besznyak, I; Diófalvi, K; Jakab, F; Kéri, G; Kopper, L; Kupcsulik, P; Mersich, T; Micsik, T; Mihalik, R; Pap, A; Petak, I; Sarkadi, B; Schafer, E; Schwab, R; Szokolóczi, O; Tihanyi, B; Tihanyi, T; Zarand, A | 1 |
1 review(s) available for fluorexon and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
12 other study(ies) available for fluorexon and Benign Neoplasms
| Article | Year |
|---|---|
Sensitive ratiometric fluorescence probe based on chitosan carbon dots and calcein for Alkaline phosphatase detection and bioimaging in cancer cells.
Topics: Alkaline Phosphatase; Carbon; Chitosan; Fluoresceins; Fluorescent Dyes; Humans; Neoplasms; Quantum Dots | 2021 |
Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer Cells
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcineurin Inhibitors; Cyclosporine; Humans; Neoplasms; Rhodamine 123; Tacrolimus | 2023 |
Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay.
Topics: CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Fluoresceins; Fluorometry; Humans; Immunotherapy; Killer Cells, Natural; Neoplasms | 2020 |
Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells.
Topics: Acoustics; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Chromatography, Gel; Cytosol; Deoxycytidine; Doxorubicin; Drug Delivery Systems; Fluoresceins; Fluorescence; Gemcitabine; Humans; Hydrogen-Ion Concentration; Liposomes; Microscopy, Atomic Force; Microscopy, Confocal; Neoplasms; Oxidation-Reduction; Particle Size; Polymers; Reducing Agents; Spectrophotometry, Ultraviolet; Spheroids, Cellular; Ultrasonics | 2014 |
Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.
Topics: Animals; Apoptosis; Breast Neoplasms; Carrier Proteins; DNA-Binding Proteins; E2F1 Transcription Factor; Female; Fluoresceins; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2014 |
Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Delivery Systems; Drug Stability; Female; Fluoresceins; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Freeze Drying; Half-Life; Humans; Liposomes; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Neoplasms; Receptors, Cell Surface; Taxoids | 2009 |
Constructing bioactive peptides with pH-dependent activities.
Topics: Amino Acid Sequence; Animals; Arginine; Cell Death; Cell Line; Fluoresceins; Histidine; Humans; Hydrogen-Ion Concentration; Lysine; Mice; Mice, Nude; Micelles; Neoplasms; Peptides; Structure-Activity Relationship; Transplantation, Homologous | 2009 |
Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Topics: Cations; Cell Line, Tumor; Chitosan; Cholesterol; Drug Delivery Systems; Flow Cytometry; Fluoresceins; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Liposomes; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Fluorescence; Neoplasms; Particle Size; Permeability; Polyethylene Glycols; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Time Factors | 2010 |
Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells.
Topics: Cell Count; Cell Line, Tumor; Cytotoxicity Tests, Immunologic; Epitope Mapping; Fluoresceins; Fluorescent Dyes; HLA-A Antigens; HLA-A2 Antigen; Humans; Immunotherapy, Adoptive; Microarray Analysis; Miniaturization; Mucin-1; Neoplasms; Peptide Fragments; T-Lymphocytes, Cytotoxic | 2010 |
Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.
Topics: Androstadienes; Cell Communication; Cell Line, Tumor; Cell Membrane; Chromones; Connexin 43; Cyclic AMP-Dependent Protein Kinases; Cytosol; Enzyme Activation; Enzyme Inhibitors; Fluoresceins; Fluorescent Antibody Technique; Gap Junctions; Humans; Immunoblotting; Isoquinolines; Morpholines; Neoplasm Metastasis; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonamides; Wortmannin | 2010 |
Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
Topics: Caco-2 Cells; Carrier Proteins; Chromatography, High Pressure Liquid; Cysteine; Doxorubicin; Fluoresceins; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Liposomes; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; Receptors, Cell Surface | 2004 |
Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers; Biopsy; Body Fluids; Carcinoma; Cell Separation; Cell Survival; Fluoresceins; Fluorescent Antibody Technique; Humans; Keratins; Leukemia P388; Neoplasms | 2007 |